In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Dr. Reddy's Laboratories Ltd.

http://www.drreddys.com

Latest From Dr. Reddy's Laboratories Ltd.

Reddy’s Settles On $7bn Revlimid But Natco Maintains The Lead

Dr Reddy’s Laboratories has become the third Revlimid ANDA sponsor to settle patent litigation action with Bristol Myers Squibb’s Celgene. However, the Indian company will join Alvogen in not being able to launch before first settler Natco, which has partnered with Teva’s Watson.

Deals Intellectual Property

Dr Reddy’s To Steer Russian COVID-19 Vaccine Plans In India

Dr Reddy’s combines forces with the Russian Direct Investment Fund for clinical trials and supply of Sputnik V in India, amid what it views as “very important” data points in early studies of the COVID-19 vaccine.

Commercial Coronavirus COVID-19

Dr Reddy’s And Perrigo Capitalize On Voltaren Switch

Seven months after GlaxoSmithKline’s Voltaren Arthritis Pain (diclofenac sodium) 1% topical gel was switched to non-prescription status in the US, two companies have begun shipping equivalent OTC versions to retailers.

Launches Prescription To Otc Switch

Supply Chain Constraints ‘Will Limit Vascepa Threat’

Supply is the million-dollar question for Vascepa ANDA sponsors, with Dr Reddy’s and Hikma receiving a further green light to introduce their generics into the US market.

Manufacturing Generic Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Other Names / Subsidiaries
    • Aurigene Discovery Technologies
    • OctoPlus N.V.
    • Promius Pharma LLC
    • Dr. Reddy's Research and Development B.V.
    • Imperial Credit Private Limited
    • Wockhardt Limited
UsernamePublicRestriction

Register